Open Access 01-12-2019 | Geriatric Oncology | Study protocol
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)
Published in: BMC Cancer | Issue 1/2019
Login to get access